Griffin Health Nuclear Medicine, Molecular Imaging and Theranostics Department has expanded its capabilities for more accurate and timely diagnoses of Parkinson’s disease with DaTscan®.
DaTscan® (Ioflupane I 123) is an innovative diagnostic molecular imaging tool used to evaluate dopamine transporter availability in the brain. DaTscan® imaging involves injecting a small amount of the radiopharmaceutical (a specialized drug that has a radioactive component) into the bloodstream, followed by a single-photon emission computed tomography (SPECT) scan to capture detailed images of the brain. This procedure is non-invasive, safe, and typically takes less than an hour to complete.
Person-Centered Diagnostics
With expansion of services to include this type of neuroimaging, Griffin Health is enhancing its ability to assist neurologists, primary care physicians and other specialists in differentiating between Parkinson’s disease and other movement disorders.
Contact Us
Griffin Health is now accepting referrals for DaTscan®. Referring providers can contact the Griffin Nuclear Medicine Department at 203-732-7271 for more information and orders can be faxed to Central Scheduling at 203-732-1559.